What is the recommended management for pes anserine bursitis after total knee arthroplasty?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Pes Anserine Bursitis After Total Knee Arthroplasty

For pes anserine bursitis following total knee arthroplasty, initiate conservative treatment with NSAIDs combined with a structured physical therapy program focusing on hamstring stretching exercises; if symptoms persist after 2-4 weeks, proceed to ultrasound-guided corticosteroid injection into the pes anserine bursa.

Understanding Post-TKA Pes Anserine Bursitis

Pes anserine bursitis after TKA is uncommon but clinically significant, occurring in approximately 5.6% of patients 1. The condition presents with inferomedial knee pain and tenderness over the proximal medial tibia, distinct from typical post-arthroplasty pain. Importantly, more than half of postoperative extra-articular symptoms (including PA tenderness) persist from the preoperative period 2, meaning many patients had subclinical inflammation before surgery that becomes symptomatic afterward.

Key Risk Factors to Identify:

  • Elevated BMI (the only independent predictor on multivariate analysis) 1
  • Female sex 1, 2
  • Absence of pes anserinus release during surgery 1

Treatment Algorithm

First-Line: Conservative Management (Weeks 1-4)

Start with oral NSAIDs combined with physical therapy 3, 4, 1. The AAOS 2022 guidelines provide strong evidence (Grade A) for NSAIDs in knee pain management 3. Specifically:

  • NSAIDs: Use standard anti-inflammatory doses (e.g., ibuprofen 600-800mg TID or naproxen 500mg BID) unless contraindicated
  • Physical therapy program: Focus on hamstring stretching exercises targeting the pes anserine insertion 4
  • Activity modification: Avoid excessive stair climbing and prolonged standing

Approximately 81.8% of patients respond to this initial conservative approach 1, making it the appropriate first step.

Second-Line: Corticosteroid Injection (Week 4-6 if conservative fails)

If symptoms persist after 4 weeks of conservative treatment, proceed to ultrasound-guided corticosteroid injection 5, 4, 6, 7. This is supported by:

  • Triamcinolone acetonide (40mg) or methylprednisolone acetate (40mg) injected directly into the pes anserine bursa under ultrasound guidance 5, 6, 7
  • The remaining 18.2% of patients who fail initial conservative treatment respond to local steroid injection 1
  • Recent comparative evidence shows corticosteroid injection provides superior short-term pain relief (1 week) compared to PRP or shockwave therapy 7

Critical technical point: Use ultrasound guidance to ensure accurate bursal placement and avoid inadvertent injection into surrounding structures 5.

Evidence Hierarchy and Nuances

The most recent high-quality study 1 from 2020 analyzing 389 TKAs provides the strongest evidence for incidence and treatment response. This study demonstrates that post-TKA pes anserine bursitis is:

  • Benign and self-limiting in nature
  • Effectively treated non-operatively in all cases
  • Never requires surgical intervention

Comparative Treatment Evidence

While newer modalities exist, the evidence favors traditional approaches:

  • Corticosteroids vs. PRP vs. Oxygen-ozone: A 2024 multicenter trial 6 showed oxygen-ozone and prolotherapy have longer-lasting effects (8 weeks), but corticosteroids provide faster initial relief (1 week). For post-TKA patients seeking rapid symptom resolution, corticosteroids remain the practical choice.
  • Corticosteroids vs. PRP vs. ESWT: A 2023 study 7 demonstrated corticosteroid injection was statistically superior at both 1 and 8 weeks for pain reduction and functional improvement.

Common Pitfalls to Avoid

  1. Misdiagnosis as infection: Post-TKA pes anserine bursitis can mimic infection with localized warmth, swelling, and pain 5, 8. Check inflammatory markers and consider ultrasound to differentiate bursal inflammation from septic arthritis.

  2. Overlooking preoperative symptoms: Since 66.1% of patients have PA tenderness before TKA 2, document preoperative extra-articular tenderness to anticipate postoperative issues.

  3. Polyethylene wear debris: In late presentations (years post-TKA), consider polyethylene-induced bursitis 8. This rare complication may present with draining sinuses and requires sinography for diagnosis.

  4. Inadequate BMI counseling: Given BMI is the only independent risk factor 1, weight reduction counseling should be emphasized as part of comprehensive management, consistent with ACR guidelines for knee OA 9.

Integration with Post-TKA Rehabilitation

Continue standard post-TKA rehabilitation protocols while treating pes anserine bursitis. The condition does not contraindicate:

  • Range of motion exercises
  • Quadriceps strengthening (strongly recommended for all post-TKA patients) 9, 10
  • Progressive weight-bearing activities

However, temporarily modify activities that directly stress the pes anserine insertion (deep knee flexion, resisted knee flexion) until symptoms improve.

When to Reassess

If symptoms persist beyond 8 weeks despite both conservative treatment and corticosteroid injection, reassess for:

  • Alternative diagnoses (stress fracture, referred pain from hip, lumbar radiculopathy)
  • Prosthetic complications (loosening, malalignment)
  • Polyethylene wear debris (in patients >5 years post-TKA) 8

References

Research

Pes anserine syndrome in post knee arthroplasty. A rare case report.

Journal of clinical orthopaedics and trauma, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.